|
MechanismnAChRα4&β2 antagonists |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismnAChRα4&β2 antagonists |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Assuage Pharmaceuticals (United States)
0 Patents (Medical) associated with Assuage Pharmaceuticals (United States)
100 Deals associated with Assuage Pharmaceuticals (United States)
100 Translational Medicine associated with Assuage Pharmaceuticals (United States)